Pharma Experts See Split On Effect Of Drug Price Negotiations
By Yeji Jesse Lee (October 6, 2023, 8:56 PM EDT) — In recent months, the pharmaceutical industry has lined up against a landmark Biden administration program aimed at driving down prescription drug costs for millions of older Americans. In the industry’s telling, discounts on medications for diabetes and other common diseases will cut so deeply into the bottom line that they will hinder investment in new drugs….
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.
No Byline Policy
Editorial Guidelines
Corrections Policy
Source